Alonso D - Search Results

1

Immunoreactivity of the 14F7 Mab raised against N-Glycolyl GM3 Ganglioside in retinoblastoma tumours.

Torbidoni AV, Scursoni A, Camarero S, Segatori V, Gabri M, Alonso D, Chantada G, de Dávila MT. Torbidoni AV, et al. Among authors: alonso d. Acta Ophthalmol. 2015 Jun;93(4):e294-300. doi: 10.1111/aos.12578. Epub 2014 Nov 17. Acta Ophthalmol. 2015. PMID: 25403557 Free article.

2

Histopathological findings in a highly invasive mouse mammary carcinoma transfected with human tissue inhibitor of metalloproteinases-1.

Alonso DF, Skilton G, De Lorenzo MS, Scursoni AM, Yoshiji H, Gomez DE. Alonso DF, et al. Oncol Rep. 1998 Sep-Oct;5(5):1083-7. doi: 10.3892/or.5.5.1083. Oncol Rep. 1998. PMID: 9683813

3

Reduction of mouse mammary tumor formation and metastasis by lovastatin, an inhibitor of the mevalonate pathway of cholesterol synthesis.

Alonso DF, Farina HG, Skilton G, Gabri MR, De Lorenzo MS, Gomez DE. Alonso DF, et al. Breast Cancer Res Treat. 1998 Jul;50(1):83-93. doi: 10.1023/a:1006058409974. Breast Cancer Res Treat. 1998. PMID: 9802623

4

A novel hydrophobized GM3 ganglioside/Neisseria meningitidis outer-membrane-protein complex vaccine induces tumor protection in B16 murine melanoma.

Alonso DF, Gabri MR, Guthmann MD, Fainboim L, Gomez DE. Alonso DF, et al. Int J Oncol. 1999 Jul;15(1):59-66. doi: 10.3892/ijo.15.1.59. Int J Oncol. 1999. PMID: 10375594

5

Role of tumor-derived granulocyte-macrophage colony-stimulating factor in mice bearing a highly invasive and metastatic mammary carcinoma.

Gabri MR, Menna PL, Scursoni AM, Gomez DE, Alonso DF. Gabri MR, et al. Among authors: alonso df. Pathobiology. 1999 Jul-Aug;67(4):180-5. doi: 10.1159/000028070. Pathobiology. 1999. PMID: 10738179

6

Antitumor properties of an anti-idiotypic monoclonal antibody in relation to N-glycolyl-containing gangliosides.

Vázquez AM, Gabri MR, Hernández AM, Alonso DF, Beausoleil I, Gomez DE, Pérez R. Vázquez AM, et al. Among authors: alonso df. Oncol Rep. 2000 Jul-Aug;7(4):751-6. doi: 10.3892/or.7.4.751. Oncol Rep. 2000. PMID: 10854538

7

Cancer vaccines: an update with special focus on ganglioside antigens.

Bitton RJ, Guthmann MD, Gabri MR, Carnero AJ, Alonso DF, Fainboim L, Gomez DE. Bitton RJ, et al. Among authors: alonso df. Oncol Rep. 2002 Mar-Apr;9(2):267-76. Oncol Rep. 2002. PMID: 11836591 Review.

8

Role of cell surface GM3 ganglioside and sialic acid in the antitumor activity of a GM3-based vaccine in the murine B16 melanoma model.

Gabri MR, Ripoll GV, Alonso DF, Gómez DE. Gabri MR, et al. J Cancer Res Clin Oncol. 2002 Dec;128(12):669-77. doi: 10.1007/s00432-002-0385-7. Epub 2002 Nov 14. J Cancer Res Clin Oncol. 2002. PMID: 12474053

9

Active specific immunotherapy of melanoma with a GM3 ganglioside-based vaccine: a report on safety and immunogenicity.

Guthmann MD, Bitton RJ, Carnero AJ, Gabri MR, Cinat G, Koliren L, Lewi D, Fernandez LE, Alonso DF, Gómez DE, Fainboim L. Guthmann MD, et al. Among authors: alonso df. J Immunother. 2004 Nov-Dec;27(6):442-51. doi: 10.1097/00002371-200411000-00004. J Immunother. 2004. PMID: 15534488 Clinical Trial.

10

Complete antitumor protection by perioperative immunization with GM3/VSSP vaccine in a preclinical mouse melanoma model.

Gabri MR, Mazorra Z, Ripoll GV, Mesa C, Fernandez LE, Gomez DE, Alonso DF. Gabri MR, et al. Clin Cancer Res. 2006 Dec 1;12(23):7092-8. doi: 10.1158/1078-0432.CCR-06-1075. Clin Cancer Res. 2006. PMID: 17145833

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

683 results

Search Page

Filters